Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates

Proteomics - Clinical Applications

Volumn 2, Issue 4, 2008, Pages 543-555

  Li, Runsheng ^a   Guo, Yan ^b   Han, Bang Ming ^c   Yan, Xiaowei ^d   Utleg, Angelita G ^d   Li, Wei ^b   Tu, Lan Chun ^d   Wang, Jian ^a   Hood, Leroy ^d   Xia, Shujie ^c   Lin, Biaoyang ^b,d  

^a SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^b Shanghai Jiao Tong University   (China)

^c SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^d INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Biomarker; Expressed prostatic secretions; Mass spectrometry; Prostate cancer

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CD14 ANTIGEN; CD143 ANTIGEN; CD177 ANTIGEN; CD224 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DIPEPTIDYL PEPTIDASE IV; KALLIKREIN; KALLIKREIN 11; KALLIKREIN 2; LYMPHOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; PROSTATE PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEOME; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; FILTRATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SECRETION; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 42449137114     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780159     Document Type: Article

References (41)

1. Lee, C., Tsai, Y., Sensibar, J., Oliver, L., Grayhack, J. T., Two-dimensional characterization of prostatic acid phosphatase, prostatic specific antigen and prostate binding protein in expressed prostatic fluid. Prostate 1986, 9, 135-146.
2. Alexander, H., Stegner, A. L., Wagner-Mann, C., Du Bois, G. C. et al., Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin. Cancer Res. 2004, 10, 7500-7510.
3. Ramstrom, M., Ivonin, I., Johansson, A., Askmark, H. et al., Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics 2004, 4, 4010-4018.
4. Cottingham, K., The cervical-vaginal fluid proteome and possible biomarkers of preterm birth. J. Proteome. Res. 2007, 6, 1241-1242.
5. Hu, S., Loo, J. A., Wang, D. T., Human body fluid proteome analysis. Proteomics 2006, 6, 6326-6353.
6. Malmstrom, J., Lee, H., Aebersold, R., Advances in proteomic workflows for systems biology. Curr. Opin. Biotechnol. 2007, 18, 378-384.
7. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N. et al., ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6, 1-6.
8. Jongeneel, C. V., Delorenzi, M., Iseli, C., Zhou, D. et al., An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome. Res. 2005, 15, 1007-1014.
9. Utleg, A. G., Yi, E. C., Xie, T., Shannon, P. et al., Proteomic analysis of human prostasomes. Prostate 2003, 56, 150-161.
10. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-6392.
11. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
12. Hood, L, Heath, J. R., Phelps, M. E., Lin, B., Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306, 640-843.
13. Diamandis, E. P., Okui, A., Mitsui, S., Luo, L. Y. et al., Human kallikrein 11: A new biomarker of prostate and ovarian carcinoma. Cancer Res. 2002, 62, 295-300.
14. Nakamura, T., Scorilas, A., Stephan, C., Jung, K. et al., The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. Cancer Res. 2003, 63, 6543-6546.
15. Zybailov, B., Coleman, M. K., Florens, L, Washburn, M. P., Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal. Chem. 2005, 77, 6218-6224.
16. Fair, W. R., Parrish, R. F., Antibacterial substances in prostatic fluid. Prog. Clin. Biol. Res. 1981, 75A, 247-264.
17. Fowler, J. E., Jr., Kaiser, D. L., Mariano, M., Immunologic response of the prostate to bacteriuria and bacterial prostatitis. I. Immunoglobulin concentrations in prostatic fluid. J. Urol. 1982, 128, 158-164.
18. Fowler, J. E., Jr., Secretory immunity of the prostate gland. Infection 1991, 19, S131-S137.
19. Jimenez-Cruz, J. F., Broseta-Rico, E., Classification, etiology, diagnosis and treatment of prostatitis. Other types of prostatitis. Acute and chronic prostatitis. Enferm. Infecc. Microbiol Clin. 2005, 23, 47-56.
20. Mandal, A., Bhattacharyya, A. K., Biochemical composition of washed human seminal coagulum in comparison to sperm-free semen from the same donors. J. Reprod. Fertil. 1990, 88, 113-118.
21. Anderson, N. L., Anderson, N. G., The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
22. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J. et al., Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2003, 2, 1096-1103.
23. Wilson, M. J., Haller, R., Li, S. Y., Slaton, J. W. et al., Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: Possible prostate cancer disease marker. J. Urol. 2005, 174, 1124-1128.
24. Crocitto, L. E., Korns, D., Kretzner, L., Shevchuk, T. et al., Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results. Urology 2004, 64, 821-825.
25. Yang, J., Ye, L., Jiang, H., Zhou, J. et al., Clinical evaluation of IL-1beta and TNF-alpha in prostatic secretions for chronic prostatitis. Zhonghua Nan Ke Xue 2004, 10, 449-450, 454.
26. Freedland, S. J., Seligson, D. B., Liu, A. Y., Pantuck, A. J. et al., Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate 2003, 55, 71-80.
27. Bogenrieder, T., Finstad, C. L., Freeman, R. H., Papandreou, C. N. et al., Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate 1997, 33, 225-232.
28. Brandt, B., Griwatz, C., Brinkmann, O., Zanker, K. S., Circulating prostate-specific antigen/CD14 double-positive cells: A biomarker indicating low risk for hematogeneous metastasis of prostate cancer. J. Natl. Cancer Inst. 1997, 89, 174.
29. Luo, W., Tapolsky, M., Earley, K., Wood, C. G. et al., Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther. 1999, 6, 313-321.
30. Busch, C., Hanssen, T. A., Wagener, C., O'Brink, B., Down-regulation of CEACAM1 in human prostate cancer: Correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum. Pathol. 2002, 33, 290-298.
31. Henttu, P., Vihko, P., Prostate-specific antigen and human glandular kallikrein: Two kallikreins of the human prostate. Ann. Med. 1994, 26, 157-164.
32. Lexander, H., Palmberg, C., Auer, G., Hellstrom, M. et al., Proteomic analysis of protein expression in prostate cancer. Anal. Quant. Cytol. Histol. 2005, 27, 263-272.
33. Hermani, A., Hess, J., De Servi, B., Medunjanin, S. et al., Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin. Cancer Res. 2005, 11, 5146-6152.
34. Koochekpour, S., Zhuang, Y. J., Beroukhim, R., Hsieh, C. L. et al., Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 2005, 44, 351-364.
35. Kang, J. S., Calvo, B. F., Maygarden, S. J., Caskey, L. S. et al., Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin. Cancer Res. 2002, 8, 117-123.
36. July, L. V., Akbari, M., Zellweger, T., Jones, E. C., et al., Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostrate 2002, 50, 179-188.
37. Jiborn, T., Abrahamson, M., Gadaleanu, V., Lundwall, A., Bjartell, A., Aberrant expression if cystatin C in prostate cancer is associated with neuroendocrine differentiation. BJU Int. 2006, 98, 189-196.
38. Zhang, Z., Bast, R. C., Jr., Yu, Y., Li, J. et al., Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004, 64, 5882-5890.
39. Chen, Y., Yu, P., Luo, J., Jiang, Y., Secreted protein prediction system combining CJ-SPHMM, TMHMM, and PSORT. Mamm. Genome 2003, 14, 859-865.
40. Porkka, K. P., Helenius. M. A., Visakorpi, T., Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate. Lab. Invest. 2002, 82, 1573-1582.
41. Hubert, R. S., Vivanco, I., Chen, E., Rastegar, S. et al., STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA 1999, 96, 14523-14528.